Aurenar
Summary active Updated Jul 30, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Founders
About
Aurenar is a St. Louis, MO-based medical device company developing a non-invasive, single-use neuromodulation platform to reduce life-threatening complications in intensive care unit (ICU) patients 12. The company’s V-Link™ platform, which recently received breakthrough device designation from the U.S. FDA, delivers transauricular vagus nerve stimulation (taVNS) to modulate the body’s inflammatory response 12. On 2026-07-28, Aurenar announced the close of an oversubscribed $5.7 million seed financing round co-led by the Go Red for Women Venture Fund™ (part of American Heart Association Ventures™) and Solas BioVentures, with additional participation from BJC Health and Kaleida Capital 123. Proceeds will fund continued advancement toward pivotal trials, including final device development, verification and validation (V&V) testing, and regulatory submissions to the FDA 12. Aurenar is led by founder and CEO Dr. Eric Leuthardt 12.
Disclaimer: This is a lean profile built from initial round coverage and may be expanded as more information becomes available.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-07-28 | Seed | $5.7M | Go Red for Women Venture Fund, Solas BioVentures | BJC Health, Kaleida Capital 123 |
What Investors Say
No independently sourced investor commentary found at time of profile creation.
What Founders Say
No independently sourced founder testimonials found at time of profile creation.
Sources
-
PR Newswire, “Aurenar Closes Oversubscribed $5.7M Seed Round Led by the Go Red for Women Venture Fund and Solas BioVentures,” July 28, 2026. Accessed July 2026. https://www.prnewswire.com/news-releases/aurenar-closes-oversubscribed-5-7m-seed-round-led-by-the-go-red-for-women-venture-fund-and-solas-bioventures-302835964.html↩↩↩↩↩↩
-
MassDevice, “Aurenar closes $5.7M seed round for noninvasive neuromod,” July 2026. Accessed July 2026. https://www.massdevice.com/aurenar-closes-seed-round-noninvasive-neuromod/↩↩↩↩↩↩
-
FinSMEs, “Aurenar Raises $5.7M in Seed Funding,” July 2026. Accessed July 2026. https://www.finsmes.com/2026/07/aurenar-raises-5-7m-in-seed-funding.html↩↩